Cohort Profile Update: The Study of Health in Pomerania (SHIP)
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The Study of Health in Pomerania (SHIP) is a population-based project, which consists of the two independent cohorts: SHIP-START and SHIP-TREND. SHIP investigates common risk factors, subclinical disorders and manifest diseases in the high-risk population of Northeast Germany. A particular characteristic of SHIP is that it does not specifically address one selected disease. It rather attempts to investigate health-related conditions with the widest scope possible. New examination waves of both cohorts were conducted to ensure longitudinal analyses. One new research focus has been laid on omics research. Information is available on genome-wide genotyping, whole-blood-transcriptome and methylome, plasma circulating miRNome, plasma proteome, plasma, urine and saliva metabolome as well as stool and saliva microbiome. The SHIP project has several collaborations and is part of many research consortia. Further collaborations are welcome; please contact Henry Völzke (voelzke@uni-greifswald.de). The Study of Health in Pomerania (SHIP) comprises the two independent cohorts SHIP-START (recruited between 1997 and 2001) and SHIP-TREND (recruited between 2008 to 2012), which were established to examine the health and disease status of the general adult population in Northeast Germany given that this region had the lowest life expectancy in Germany in the 1990s.1 The initial cohort was renamed SHIP-START to avoid confusion with designation of SHIP, as the whole project comprises different cohorts. Both cohorts serve the purpose of understanding the concepts of health and disease in their greatest possible complexity, rather than focusing on specific disease areas. Consequently, the examination programmes are the most comprehensive that have ever been applied to a general population sample worldwide; the baseline examinations of SHIP-TREND took ≤25 h. The second follow-up of SHIP-START (SHIP-START-2) and baseline SHIP-TREND-0 were the first studies worldwide to utilize whole-body magnetic resonance imaging (MRI) in a general population setting.2 The major aims of the SHIP project include the investigation of disease incidences and the analysis of the relationships between risk factors, subclinical disorders and disease outcomes on a longitudinal scale. To achieve this, repeated examinations of each cohort have been conducted. To associate the longitudinal change in risk factors and subclinical disorders with incident outcomes, SHIP databases are linked with external data sources including population registries, health agencies, hospitals and the regional association of statutory health insurances physicians. In-depth diagnostic interviews and assessments for personality factors and mental disorders were introduced in SHIP-LEGEND (2007–2010), which was part of SHIP-START.1 One new research focus has been laid on omics research. For past years, information has been substantially broadened by performing omics analyses of stored SHIP biomaterials. Genome-wide genotyping data are available and, in addition, analyses were performed of whole-blood-transcriptome and methylome, plasma circulating miRNome, plasma proteome, plasma, urine and saliva metabolome as well as stool and saliva microbiome. With these data, SHIP is actively participating in international consortia including euCanSHare,3 THYROIDOMICS,4 CHARGE,5 GIANT6 and ENIGMA,7 to name but a few. Whole-body MRI is an effective and accurate method to collect comprehensive information on organ morphology and function. Given the high demand on standardization and the ineffectiveness of human readings, (semi-)automated algorithms are the method of choice to extract information from images in large cohorts. When implementing MRI in SHIP, however, such algorithms were often not available, particularly for abdominal organs. Therefore, respective software was developed in-house.8,9 Segmentation results are then analysed for potential associations with disease risks and to establish reference intervals of organ size and function.10 SHIP is also used as a basis for meta-research with a particular focus on incidental MRI findings and their effects on study participants.11,12 With its large amount of standardized data and the option to internally replicate findings from SHIP-START using data of the independent SHIP-TREND, the project offers good opportunities to apply new bioinformatical tools to mine the data and gain new insights into risk factors and pathomechanisms. These tools are increasingly used with respect to different outcomes including hypertension,13 hepatic steatosis14 and Alzheimer’s disease.15 For omics analyses and data-mining projects, replication is needed to validate findings. Against this background, large international consortia were formed. One weakness, however, is the sometimes limited comparability of phenotypic variables.16 Therefore, SHIP scientists increasingly cooperate with external colleagues, who plan to establish population-based cohorts in their regio
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
The FAIR Guiding Principles for scientific data management and stewardship
Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.18 · Cited by 18,423
SAUNDERS, J. B., AASLAND, O. G., BABOR, T. F., DE LA FUENTE, J. R., & GRANT, M. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02093.x · Cited by 13,597
Sherbourne, C. D., & Stewart, A. L. (1991) · Social Science & Medicine · doi:10.1016/0277-9536(91)90150-b · Cited by 6,643
BERKMAN, L. F., & SYME, S. L. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112674 · Cited by 5,341
Genetic studies of body mass index yield new insights for obesity biology
Study, T. L. C., Locke, A. E., The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The, G. L. G. C., The, I. C. B. P., The MAGIC Investigators, The MuTHER Consortium, et al. (2015) · Nature · doi:10.1038/nature14177 · Cited by 4,534
Self-citationThe functional gastrointestinal disorders and the Rome III process
Drossman, D. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.008 · Cited by 2,416
Development of the 25-list-item National Eye Institute Visual Function Questionnaire
Mangione, C. M. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.7.1050 · Cited by 2,230
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data
the Alzheimer’s Disease Neuroimaging Initiative, E. C., Thompson, P. M., Stein, J. L., Medland, S. E., Hibar, D. P., Vasquez, A. A., Renteria, M. E., Toro, R., Jahanshad, N., Schumann, G., et al. (2014) · Brain Imaging and Behavior · doi:10.1007/s11682-013-9269-5 · Cited by 838
Self-citationGenome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation
Teumer, A., Chaker, L., Groeneweg, S., Li, Y., Di Munno, C., Barbieri, C., Schultheiss, U. T., Traglia, M., Ahluwalia, T. S., Akiyama, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06356-1 · Cited by 280
Self-citation
Cited by
Hempel, P., Ribeiro, A. H., Vollmer, M., Bender, T., Dörr, M., Krefting, D., & Spicher, N. (2025) · npj Digital Medicine · doi:10.1038/s41746-024-01428-7 · Cited by 31
Self-citationAssociations of Pulmonary Function with MRI Brain Volumes: A Coordinated Multi-Study Analysis
Frenzel, S., Bis, J. C., Gudmundsson, E. F., O’Donnell, A., Simino, J., Yaqub, A., Bartz, T. M., Brusselle, G. G. O., Bülow, R., DeCarli, C. S., et al. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220667 · Cited by 22
Self-citationSager, P., Kocher, T., Pitchika, V., Samietz, S., Völzke, H., Walter, C., & Holtfreter, B. (2023) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13763 · Cited by 12
Self-citation
Metadata
- Authors
- Völzke, H., Schössow, J., Schmidt, C. O., Jürgens, C., Richter, A., Werner, A., Werner, N., Radke, D., Teumer, A., Ittermann, T., Schauer, B., Henck, V., Friedrich, N., Hannemann, A., Winter, T., Nauck, M., Dörr, M., Bahls, M., Felix, S. B., Stubbe, B., Ewert, R., Frost, F., Lerch, M. M., Grabe, H. J., Bülow, R., Otto, M., Hosten, N., Rathmann, W., Schminke, U., Großjohann, R., Tost, F., Homuth, G., Völker, U., Weiss, S., Holtfreter, S., Bröker, B. M., Zimmermann, K., Kaderali, L., Winnefeld, M., Kristof, B., Berger, K., Samietz, S., Schwahn, C., Holtfreter, B., Biffar, R., Kindler, S., Wittfeld, K., Hoffmann, W., & Kocher, T.
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-03-29
- Volume
- 51
- Issue
- 6
- Pages
- e372-e383
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W4214687994
- Cited by
- 211
- References
- 13
- FWCI
- 14.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cohort Profile Update: The Study of Health in Pomerania (SHIP). https://app.cochat.ai/papers/10.1093/ije/dyac034
- The paper
- Völzke, H., Schössow, J., Schmidt, C. O., Jürgens, C., Richter, A., Werner, A., Werner, N., Radke, D., Teumer, A., Ittermann, T., Schauer, B., Henck, V., Friedrich, N., Hannemann, A., Winter, T., Nauck, M., Dörr, M., Bahls, M., Felix, S. B., . . . Kocher, T. (2022). Cohort Profile Update: The Study of Health in Pomerania (SHIP). International Journal of Epidemiology. https://doi.org/10.1093/ije/dyac034
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.